LCZ696治疗高血压肾损害的研究进展  

The Prospect of Treating Hypertensive Kidney Lesion with LCZ696

作　　者：金林 刘云启[1] 潘立平[1] JIN Lin;LIU Yunqi;PAN Liping(Nephrology Department,Binzhou Medical University Hospital,Shandong Binzhou 256600,China)

机构地区：[1]滨州医学院附属医院肾内科

出　　处：《中国医药导刊》2019年第9期560-563,共4页Chinese Journal of Medicinal Guide

摘　　要：长期的高血压会导致肾脏功能损害,肾脏功能损害后也会引起高血压,两者互为因果。高血压肾损害的发病是由多种因素共同导致的,例如血管容量负荷增加、肾素-血管紧张素系统异常、氧化应激与炎性反应以及遗传和代谢因素。LCZ696能通过调控肾素-血管紧张素系统,降低容量负荷,显著降低高血压。本文通过详细介绍高血压肾损害的发病机制,以及LCZ696的作用机制及近期研究,综述LCZ696治疗对肾脏病的研究进展。Chronic hypertension can lead to kidney lesion,and chronic kidney disease can also lead to hypertension,both of which are mutually causal.Hypertensive kidney lesion is caused by a combination of factors,such as increased vascular volume load,renin-angiotensin system abnormalities,oxidative stress and inflammatory responses,genetic and metabolic factors.LCZ696 can control renin-angiotensin system,reduce volume load,significantly reduce hypertension.In this paper,we reviewed the progress of LCZ696 treating renal disease by introducing the pathogenesis of renal damage of hypertension,the action mechanism of LCZ696 and the related recent studies.

关 键 词：LCZ696 脑啡肽酶抑制剂 血管紧张素受体抑制剂 高血压肾损害 

分 类 号：R544.1[医药卫生—心血管疾病]